Investing First patient dosed in Phase IIb imaging for Brain Mets by admin April 28, 2025 April 28, 2025 Radiopharm Theranostics (RAD:AU) has announced First patient dosed in Phase IIb imaging for Brain Mets Download the PDF here. This post appeared first on investingnews.com previous post Binding Commitments Received for A$1.0 Million under Convertible Note Placement next post RHI: Acqn of royalty over Sandstone Gold Project tenements You may also like Homerun Resources: Establishing a Vertically Integrated Leader in... August 20, 2025 WGC: Surging Gold Prices Drive Record Q2 Investment... August 5, 2025 Editor’s Picks: Historic Week — Gold Breaks US$4,000,... October 11, 2025 East Star and Endeavour Mining to Collaborate on... November 18, 2025 Silver47 Announces Graduation to Tier 1 Status on... May 23, 2025 Locksley Resources: High-grade Antimony & Rare Earths Prospects... September 30, 2025 Westport Announces Annual General and Special Meeting and... April 18, 2025 High Grade Cu-Au at Surface Delivers New Targets... July 9, 2025 4 Biggest Cybersecurity ETFs in 2025 April 29, 2025 Silver Crown Royalties Announces Closing of First Tranche... June 24, 2025